Lv5
1160 积分 2022-08-02 加入
Breast cancer
1天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
3个月前
已完结
Multidisciplinary Management of Brain Metastasis from Breast Cancer
4个月前
已完结
Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
4个月前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
4个月前
已完结
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
9个月前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
10个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
11个月前
已完结
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma
1年前
已完结
皖公网安备34019202002308
